Skin bleaching TFM
This article was originally published in The Tan Sheet
Executive Summary
Hydroquinone will "probably" become nonmonograph, FDA's OTC Monograph Review Staff Director William Gilbertson told a Society of Cosmetic Chemists' sunscreen symposium on Oct. 2. The skin bleaching tentative final monograph will be proposed by FDA a second time and will include data from a 1989 National Toxicology Program study linking the ingredient to possible carcinogenic effects as well as FDA's assessment of that data. The agency has said that the new TFM could be out this year. Currently, hydroquinone in 1.5%-2% concentrations is the only approved ingredient in the TFM.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning